p38MAPK activation and DUSP10 expression in meningiomas

Mahlon D Johnson1, Jay E Reeder2, Mary O'Connell1

  • 1Department of Pathology, Division of Neuropathology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 626, Rochester, NY 14623, USA.

Insights

Mitogen-activated protein kinase (MAPK) p38MAPK and dual-specificity phosphatase 10 (DUSP10) are involved in meningioma cell growth. DUSP10 expression inversely correlates with p38MAPK phosphorylation in most meningiomas, suggesting a role in tumor development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mitogen-activated protein kinase (MAPK) p38MAPK is crucial for cell proliferation and apoptosis.
  • The role of p38MAPK, its activation, and regulation by dual-specificity phosphatases (DUSP), specifically DUSP10, in meningiomas remains uncharacterized.
  • DUSP10 is a potential regulator of meningioma cell proliferation.

Purpose of the Study:

  • To investigate the expression, activation, and regulation of DUSP10 and p38MAPK signaling in human meningiomas.
  • To explore the in vitro effects of platelet-derived growth factor-BB (PDGF-BB) and transforming growth factor B1 (TGFB1) on DUSP10 and MAPK signaling in meningioma cultures.

Main Methods:

  • Western blot analysis was used to detect DUSP10 and phosphorylated p38MAPK and p44/42MAPK.
  • Polymerase chain reaction (PCR) was employed to assess DUSP10 expression.
  • In vitro studies examined the effects of PDGF-BB, TGFB1, and cerebrospinal fluid on meningioma cells.

Main Results:

  • DUSP10 and phosphorylated p38MAPK/p44/42MAPK were present in normal leptomeninges and meningiomas across all World Health Organization grades.
  • DUSP10 expression generally showed an inverse correlation with p38MAPK phosphorylation in meningiomas.
  • PDGF-BB upregulated DUSP10, while TGFB1 increased p38MAPK phosphorylation and caspase 3 activation.

Conclusions:

  • p38MAPK and DUSP10 are likely involved in the pathogenesis of meningiomas.
  • The interplay between DUSP10 and p38MAPK signaling pathways may represent a therapeutic target for meningioma treatment.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K